Markets Stocks Economy Crypto Earnings Banking Energy
Home Earnings Feature
Earnings · Exclusive

Oppenheimer expects e.l.f. Beauty to beat Q1 estimates, lift guidance

Oppenheimer expects e.l.f. Beauty to beat Q1 estimates, lift guidance
Earnings · 2026
Photo · Hannah Cole for Daily Digest Invest
By Hannah Cole Earnings Reporter Aug 3, 2026 4 min read

Investment bank Oppenheimer is telling clients that e.l.f. Beauty is likely to deliver better-than-expected results for its fiscal first quarter, and may lift its full-year outlook when it reports on August 5. The key driver, according to the bank, is the recently acquired rhode brand, which is expected to help offset any lingering softness in the core e.l.f. business.

The note comes as e.l.f. Beauty has been navigating a tougher environment for cosmetics spending. The company has cut prices on some products and rolled out new growth initiatives to reignite demand. Oppenheimer says it is watching closely to see whether those efforts are starting to show "green shoots" — early signs of improvement that could signal a turnaround.

What's behind the optimism?

Oppenheimer's view is that rhode, the skincare and makeup brand founded by Hailey Bieber, will be a meaningful contributor in the quarter. e.l.f. Beauty completed its acquisition of rhode earlier this year, and the brand has a strong following among younger consumers. The bank expects rhode's sales to help offset any weakness in the legacy e.l.f. product lines, which have faced tougher comparisons and increased competition.

The bank also points to e.l.f.'s price cuts as a potential positive. By lowering prices on certain items, the company is trying to win back budget-conscious shoppers who have been trading down or delaying purchases. While price cuts can pressure margins in the short term, they can also drive higher volume and market share if they resonate with consumers.

Oppenheimer's expectation of a beat and higher guidance suggests the bank believes these efforts are already gaining traction. A "beat" means the company's actual results come in above Wall Street's forecasts, while "higher guidance" means management raises its own outlook for future sales or profit.

Why this matters for investors

For everyday investors, the key takeaway is that e.l.f. Beauty's stock could react positively if the company delivers on Oppenheimer's expectations. When a company beats estimates and raises guidance, it often signals that business is improving, which can boost investor confidence and support the share price.

However, it's important to remember that analyst forecasts are not guarantees. Companies can miss expectations, and even a beat can be overshadowed by cautious commentary about the future. Investors should wait for the actual earnings report on August 5 before making any decisions.

The broader context is also worth noting. The beauty and personal care sector has been resilient overall, but consumer spending has become more selective as inflation and interest rates remain elevated. Companies that can offer value and innovation tend to perform better in this environment. e.l.f. Beauty has historically been a strong performer in the mass-market segment, and its acquisition of rhode gives it a foothold in the premium skincare space.

What to watch in the report

When e.l.f. Beauty reports, investors will be looking at several key metrics:

  • Revenue growth: How much did sales increase compared to the same quarter last year? A strong top line would support the case that price cuts and new products are working.
  • Margins: Price cuts can squeeze profitability, so watch whether gross margins hold up better than expected.
  • rhode's contribution: The acquisition is new, so investors will want to see how much rhode added to sales and whether it's on track to meet its growth targets.
  • Guidance: Management's outlook for the rest of the year will be crucial. If they raise guidance, it suggests confidence in the momentum.

Oppenheimer's note is just one analyst's view, but it adds to the narrative that e.l.f. Beauty may be turning a corner. The company has faced headwinds from softer demand and increased competition, but the rhode acquisition and pricing strategy could provide the boost it needs.

For investors, the upcoming earnings report is a key catalyst. If the company delivers as Oppenheimer expects, it could be a positive sign for the stock. If not, the stock could face pressure. As always, it's wise to consider your own financial situation and risk tolerance before acting on any single analyst's opinion.

More from this story

Next article · Don't miss

Visa to Buy Fraud Firm BioCatch for $2.4 Billion as Yields Ease

Visa is paying $2.4 billion in cash for BioCatch, a fraud intelligence firm. The deal comes as 10-year Treasury yields slipped to 4.69%, helping financial stocks edge higher.

Read the story →
Visa to Buy Fraud Firm BioCatch for $2.4 Billion as Yields Ease